Insights Into Arrowhead Pharmaceuticals Inc (ARWR) Exposure By Institutions

After Hours

It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.

Stocks Info

Arrowhead Pharmaceuticals Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Arrowhead Pharmaceuticals Inc is $2.46B. A total of 1.72 million shares were traded on the day, compared to an average of 1.45M shares.

In the most recent transaction, Hamilton James C sold 32,729 shares of ARWR for 19.82 per share on Jan 06 ’25. After the transaction, the Chief Discovery/Trans Medicine now owns 272,122 company shares. In a previous transaction on Jan 06 ’25, O’Brien Patrick sold 29,184 shares at 19.82 per share. ARWR shares that COO and General Counsel owns now total 535,201.

Among the insiders who sold shares, O’Brien Patrick disposed of 8,000 shares on Jan 07 ’25 at a per-share price of $19.69. This resulted in the COO and General Counsel holding 527,201 shares of ARWR after the transaction. In another insider transaction, Myszkowski Kenneth Allen sold 27,167 shares at $19.83 per share on Jan 06 ’25. Company shares held by the Chief Financial Officer now total 473,433.

Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, ARWR has a high of $39.83 and a low of $17.05.

Balance Sheet Annually/Quarterly

As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. ARWR’s latest balance sheet shows that the firm has $367.79M in Cash & Short Term Investments as of fiscal 2021. There were $25.55M in debt and $146.54M in liabilities at the time. Its Book Value Per Share was $1.49, while its Total Shareholder’s Equity was $408.82M.

Analysts Opinion

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ARWR is Buy with a score of 4.27.

Most Popular

Related Posts